H.R. 1620 · 119th Congress
Finn Sawyer Access to Cancer Testing Act
Key: what the circles and colors mean
Each circle is a bill. The ring fills as it moves through Congress:
Under the number: the Yea · Nay count of its final (or latest) recorded vote. On a member's page, the small badge is how that member voted: Y Yea / Aye, N Nay / No, P Present, – Not voting.
Gold and violet are only for Yea and Nay; they never mean a party. A member's party is the letter on their photo.
Not yet voted on. This bill is still a proposal: it hasn't reached a floor vote, and its text can change in committee or on the floor before any vote.
D
MatsuiSponsor13 cosponsors · 11 D, 2 R
R
Bilirakis
DB
R
Bacon
DD
D
Davis
RG
D
Grijalva
JH
D
Himes
GL
D
Landsman
TS
D
Sewell
MT
D
Thompson
RT
D
Tlaib
DW
D
Wasserman Schultz
JG
D
Gottheimer
PT
D
Tonko
CP
D
Pingree10 signed on when it was introduced; the rest joined later. Cosponsors who withdrew aren't shown.
This bill provides for coverage of certain cancer diagnostic and laboratory tests under Medicare, Medicaid, and the Children's Health Insurance Program (CHIP). Specifically, the bill provides for coverage of microarray analysis, DNA and RNA sequencing, whole-exome sequencing, and other next-generation sequencing for individuals diagnosed with cancer.
What it does: CRS summary · Introduced in House · Feb 26, 2025
Finn Sawyer Access to Cancer Testing Act
This bill provides for coverage of certain cancer diagnostic and laboratory tests under Medicare, Medicaid, and the Children's Health Insurance Program (CHIP). Specifically, the bill provides for coverage of microarray analysis, DNA and RNA sequencing, whole-exome sequencing, and other next-generation sequencing for individuals diagnosed with cancer.
Additionally, the Department of Health and Human Services must establish an education and awareness program for physicians and the public about genomic testing and the role of genetic counselors.
Written by the nonpartisan Congressional Research Service. All summary versions on Congress.gov
About this bill and sources
Official title: Finn Sawyer Access to Cancer Testing Act
Latest action (Feb 26, 2025): Referred to the Committee on Energy and Commerce, and in addition to the Committee on Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
Policy area: Health · Origin: House · Introduced: Feb 26, 2025
Official page on Congress.gov · Bill text (GovInfo) · Status record (XML)
No recorded floor vote found.